Market Research Logo

Global Womens Health Market 2016-2020

About Women's Health Market

Women’s health refers to the overall well-being experienced by women — this includes physical, mental, and social well-being. It deals with the diagnosis and treatment of various diseases and conditions that affect women such as HIV/AIDS, endometriosis, infertility, polycystic ovary syndrome, postmenopausal osteoporosis, and cancer (primarily ovarian and breast cancer). It also includes issues other than the biological conditions, like gender inequality (women are sometimes not able to afford medical treatments) or other socioeconomic issues.

Technavio’s analysts forecast the global women's health market to grow at a CAGR of 3.84% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global women's health market for 2016-2020. To calculate the market size, the report considers the revenue generated by the sales of drugs and devices for women's health issues.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • Europe
  • MEA
Technavio's report, Global Women's Health Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Allergan
  • Bayer HealthCare
  • Merck
  • Pfizer
  • Teva Pharmaceuticals
Other prominent vendors
  • Agile Therapeutics
  • Amgen
  • Apothecus Pharmaceutical
  • AstraZeneca
  • Blairex Laboratories
  • Bristol-Myers Squibb
  • EffRx
  • Ferring International Center
  • GlaxoSmithKline
  • HLL Lifecare
  • Janssen Pharmaceutical
  • Lipocine
  • Ligand Pharmaceuticals
  • Lupin Pharmaceuticals
  • Mayer Laboratories
  • Medicines 360
  • Neurocrine Biosciences
  • Novartis
  • Novo Nordisk
  • Pantarhei Bioscience
  • Sanofi
Market driver
  • Rise in number of older women worldwide
  • For a full, detailed list, view our report
Market challenge
  • High cost and inaccessibility of health services
  • For a full, detailed list, view our report
Market trend
  • Rise in STIs
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Women's Health Market 2016-2020

Technavio recognizes the following companies as the key players in the Global Women's Health Market: Allergan, Bayer HealthCare, Merck, Pfizer, and Teva Pharmaceuticals.

Other Prominent Vendors in the market are: Agile Therapeutics, Amgen, Apothecus Pharmaceutical, AstraZeneca, Blairex Laboratories, Bristol-Myers Squibb, EffRx, Ferring International Center, GlaxoSmithKline, HLL Lifecare, Janssen Pharmaceutical, Lipocine, Ligand Pharmaceuticals, Lupin Pharmaceuticals, Mayer Laboratories, Medicines 360, Neurocrine Biosciences, Novartis, Novo Nordisk, Pantarhei Bioscience, and Sanofi.

Commenting on the report, an analyst from Technavio’s team said: “The limited funding for public health clinics globally has led to a rise in common STIs such as chlamydia, syphilis, and gonorrhea. Such diseases should be treated urgently as they can cause pelvic inflammatory diseases, stillbirths, neonatal infections, and infertility. Various public health institutes highly recommend that women who are sexually active must undergo STI screening once a year. The increase in detections of STIs will positively affect this market.”

According to the report, the rise in the number of older women worldwide has spurred the market, with companies investing in R&D to develop new women's health solutions to enhance their existing portfolio. Many of the diseases women are diagnosed with are associated with old age. This will fuel the growth of the women's health market over the forecast period.

Further, the report states that one of the major issues faced by women is the cost of treatment and the inaccessibility of therapies to treat diseases, especially in developing and under-developing countries.

Companies Mentioned

Allergan, Bayer HealthCare, Merck, Pfizer, Teva Pharmaceuticals, Agile Therapeutics, Amgen, Apothecus Pharmaceutical, AstraZeneca, Blairex Laboratories, Bristol-Myers Squibb, EffRx, Ferring International Center, GlaxoSmithKline, HLL Lifecare, Janssen Pharmaceutical, Lipocine, Ligand Pharmaceuticals, Lupin Pharmaceuticals, Mayer Laboratories, Medicines 360, Neurocrine Biosciences, Novartis, Novo Nordisk, Pantarhei Bioscience, Sanofi.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
      • Table Global women's health market segmentation
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global women's health market 2015-2020 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by application
    • Market overview
      • Table Global women's health market segmentation by application 2015
      • Table Global women's health market segmentation by application 2020
      • Table Global women's health market by application 2015-2020 ($ billions)
      • Table Global women's health market by application 2015-2020 (% share)
    • Global postmenopausal osteoporosis market
      • Table Global postmenopausal osteoporosis market 2015-2020 ($ billions)
    • Global contraceptives market
      • Table Global contraceptives market 2015-2020 ($ billions)
    • Global infertility market
      • Table Global infertility market 2015-2020 ($ billions)
    • Global menopause market
      • Table Global menopause market 2015-2020 ($ billions)
    • Global endometriosis market
      • Table Global endometriosis market 2015-2020 ($ billions)
    • Global polycystic ovary syndrome market
      • Table Global polycystic ovary syndrome market 2015-2020 ($ millions)
  • Geographical segmentation
    • Market overview
      • Table Global women's health market geographical segmentation 2015
      • Table Global women's health market geographical segmentation 2015-2020 ($ billions)
    • Women's health market in Americas
      • Table Women's health market in Americas 2015-2020 ($ billions)
    • Women's health market in Europe
      • Table Women's health market in Europe 2015-2020 ($ billions)
    • Women's health market in APAC
      • Table Women's health market in APAC 2015-2020 ($ billions)
    • Women's health market in MEA
      • Table Women's health market in MEA 2015-2020 ($ billions)
  • Market drivers
    • Table Average annual per capita growth in health spending and share of GDP in emerging countries and OECD for 2013-2014
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Table Companies focusing on women's health
  • Vendor landscape
    • Competitive scenario
  • Key vendor analysis
    • Allergan
      • Table Allergan: Key takeaways
    • Bayer HealthCare
      • Table Bayer HealthCare: Key takeaways
    • Merck
      • Table Merck: Key takeaways
    • Pfizer
      • Table Pfizer: Key takeaways
    • Teva Pharmaceuticals
      • Table Teva Pharmaceuticals: Key takeaways
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report